Form EFFECT Adaptimmune Therapeutics
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | November 14, 2025 |
| Accession Number: | 0001104659-25-103158 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- 21Shares AG (the “Issuer”): Publication of a Supplementary Prospectus
- GoCharting Launches the World's First Order-Flow, Charting and Technical Analysis Platform for Prediction Markets
- American Council of Learned Societies Announces 2026 Digital Justice Grantees
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
